Commensal bacteria promote azathioprine-therapy-failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability
Yuqing Yan(Shanghai Jiao Tong University), Jie Hong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Muni Hu(Shanghai Jiao Tong University), Zhe Cui(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Lijun Ning(Shanghai Institute of Hematology), Zhenhua Wang, Yanru Ma(Renji Hospital), Ziyun Gao(Nanchang University), Xiaowen Huang(Guangzhou University of Chinese Medicine), Tianying Tong(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Ying Zhao(Shanghai Institute of Hematology), Yilu Zhou(Shanghai Jiao Tong University)
Cited by 2
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231